Is Teva Among Finalists In Bidding For Germany's Ratiopharm? (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Ratiopharm would bring market share, geographic diversification, and an attractive OTC business - if the price is right.